NEW YORK (GenomeWeb News) - GVK Biosciences is collaborating with Crelux to offer biopharmaceutical companies an integrated drug discovery and development platform for use in structure-based drug design programs, Hyderabad, India-based GVK Bio said today.

GVK Bio will conduct in silico, in vitro, and in vivo studies and functions related to preclinical candidate nomination, while Munich-based Crelux will perform multifaceted structural studies toward X-ray elucidation of fragment or lead target complexes.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.